Sodium NItroPrusside Treatment in Acute Heart Failure

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

October 15, 2021

Study Completion Date

November 23, 2021

Conditions
Acute Heart Failure
Interventions
DRUG

SNP - Sodium Nitroprusside

The primary objective of our study is to assess the efficacy and safety of SNP as part of the treatment regimen of AHF patients and to identify predictors of efficacy.

Trial Locations (1)

20162

ASST Grande Ospedale Metropolitano Niguarda, Milan

All Listed Sponsors
lead

Niguarda Hospital

OTHER